Small animal models for acquired immune deficiency syndrome (AIDS) research

Laboratory Animal Science

Volumn 46, Issue 3, 1996, Pages 257-265

  Mosier, Donald E ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL; C57BL MOUSE; DISEASE MODEL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METHODOLOGY; MOUSE; MOUSE MUTANT; PATHOGENICITY; REVIEW; RODENT DISEASE; VIROLOGY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANIMALS; DISEASE MODELS, ANIMAL; HIV INFECTIONS; HIV-1; HIV-2; MICE; MICE, INBRED C57BL; MICE, SCID; MURINE ACQUIRED IMMUNODEFICIENCY SYNDROME; RESEARCH DESIGN;

EID: 0030161655     PISSN: 00236764     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (106)

1. Mosier, D. E. 1986. Animal models for retrovirus-induced immunodeficiency disease. Immunol. Invest. 15:233-261.
2. Barre-Sinoussi, F., J. C. Chermann, F. Rey, et al. 1983. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 220:868-871.
3. Gallo, R. C., S. Z. Salahuddin, M. Popovic, et al. 1984. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science 224:500-503.
4. Popovic, M., M. G. Sarngadharan, E. Read, et al. 1984. Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science 224:497-500.
5. Gardner, M. B. 1989. SIV infected rhesus macaques: an AIDS model for immunoprevention and immunotherapy. Adv. Exp. Med. Biol. 251:279-293.
6. Sparger, E. E., P. A. Luciw, J. H. Elder, et al. 1989. Feline immunodeficiency virus is a lentivirus associated with an AIDS-like disease in cats. AIDS 3:S43-S49.
7. Fultz, P. N., H. M. McClure, R. B. Swenson, et al. 1986. Persistent infection of chimpanzees with human T-lymphotropic virus type III/lymphadenopathy-associated virus: a potential model for acquired immunodeficiency syndrome. J. Virol. 58:116-124.
8. Kulaga, H., T. Folks, R. Rutledge, et al. 1989. Infection of rabbits with human immunodeficiency virus 1. J. Exp. Med. 169:321-326.
9. Mosier, D. E., R. J. Gulizia, S. M. Baird, et al. 1988. Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature (London) 335:256-259.
10. Mosier, D. E., R. J. Gulizia, S. M. Baird, et al. 1991. Human immunodeficiency virus infection of human-PBL-SCID mice. Science 251:791-794.
11. McCune, J. M., R. Namikawa, H. Kaneshima, et al. 1988. The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science 241:1632-1639.
12. Kaneshima, H., C-C. Shih, R. Namikawa, et al. 1991. Human immunodeficiency virus infection of human lymph nodes in the SCID-hu mouse. Proc. Natl. Acad. Sci. USA 88:4523-4527.
13. Aldrovandi, G., G. Feuer, L. Gao, et al. 1993. The SCID-hu mouse as a model for HIV-1 infection Nature 363:732-736.
14. Mosier, D. E., R. A. Yetter, and H. C. Morse III. 1985. Retroviral induction of acute lymphoproliferative disease and profound immunosuppression in adult C57BL/6 mice. J. Exp. Med. 161:766-784.
15. Morse, H. C., III, S. K. Chattopadhyay, M. Makino, et al. 1992. Retrovirus-induced immunodeficiency in the mouse: MAIDS as a model for AIDS. AIDS 6:607-621.
16. Jolicoeur, P. 1991. Murine acquired immunodeficiency syndrome (MAIDS): an animal model to study the AIDS pathogenesis. FASEB J. 5:2398-2405.
17. Maddon, P. J., A. G. Dalgleish, J. S. McDougal, et al. 1986. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell 47:333-348.
18. Mosier, D. E. 1994. Consequences of secondary or co-infections for immunity. Curr. Opin. Immunol. 6:539-544.
19. Gazzinelli, R. T., J. W. Hartley, T. N. Fredrickson, et al. 1992. Opportunistic infections and retrovirus-induced immunodeficiency: studies of acute and chronic infections with Toxoplasma gondii in mice infected with LP-BM5 murine leukemia viruses. Infect. Immun. 60:4394-4401.
20. Bonagura, V. R., S. L. Cunningham-Rundles, and S. Schuval. 1992. Dysfunction of natural killer cells in human immunodeficiency virus-infected children with or without Pneumocystis carinii pneumonia. J. Pediatr. 121:195-201.
21. Chehimi, J., S. Bandyopadhyay, K. Prakash, et al. 1991. In vitro infection of natural killer cells with different human immunodeficiency virus type 1 isolates. J. Virol. 65:1812-1822.
22. Poli, G., and A. Fauci. 1992. The role of monocyte/ macrophages and cytokines in the pathogenesis of HIV infection. Pathobiology 60:246-251.
23. Dupuy, J. M., P. N. Fultz, R. Kurth, et al. 1990. Report of a WHO informal consultation on animal models for evaluation of drugs and vaccines for HIV infection and AIDS (WHO Geneva, 14-15 September 1989). Biologicals 18:225-234.
24. Du, Z., S. M. Lang, V. G. Sasseville, et al. 1995. Identification of a nef allele that causes lymphocyte activation and acute disease in macaque monkeys. Cell 82:665-674.
25. smm-PBj14. Nature 345:636-640.
26. Rezikyan, S., E. E. Kaaya, M. Ekman, et al. 1995. B-cell lymphomagenesis in SIV-immunosuppressed cynomolgus monkeys. Int. J. Cancer 61:574-579.
27. Lane, T. E., M. J. Buchmeier, D. D. Watry, et al. 1995. Serial passage of microglial SIV results in selection of homogeneous env quasispecies in the brain. Virology 212:458-465.
28. Watry, D., T. E. Lane, M. Streb, et al. 1995. Transfer of neuropathogenic simian immunodeficiency virus with naturally infected microglia. Am. J. Pathol. 146:914-923.
29. Henriksen, S. J., O. Prospero-Garcia, T. R. Phillips, et al. 1995. Feline immunodeficiency virus as a model for study of lentivirus infection of the central nervous system. Curr. Topics Microbiol. Immunol. 202:167-186.
30. Mosier, D., R. Gulizia, P. MacIsaac, et al. 1993. Rapid loss of CD4+ T cells in human-PBL-SCID mice by noncytopathic HIV isolates. Science 260:689-692.
31. Namikawa, R., H. Kaneshima, M. Lieberman, et al. 1988. Infection of the SCID-hu mouse by HIV-1. Science 242:1684-1686.
32. Bonyadi, M., L. Rabin, S. Salimi, et al. 1993. HIV induces thymus depletion in vivo. Nature 363:728-732.
33. Picchio, G. R., J. I. Cohen, E. R. Wyatt, et al. 1993. Enhanced tumorigenicity of an Epstein-Barr virus-transformed lymphoblastoid cell line is associated with a unique 1:18 chromosomal translocation and decreased expression of lymphocyte function associated antigen-la (CD11a). Am. J. Pathol. 143:342-349.
34. Rochford, R., and D. Mosier. 1994. Immunobiology of Epstein-Barr virus-associated lymphomas. Clin. Immunol. Immunopathol. 71:256-259.
35. Gardner, M. B., and P. A. Luciw. 1989. Animal models of AIDS. FASEB J. 3:2593-2606.
36. Chattopadhyay, S. K., H. C. Morse III, M. Makino, et al. 1989. Defective virus is associated with induction of murine retrovirus-induced immunodeficiency syndrome. Proc. Natl. Acad. Sci. USA 86:3862-3866.
37. Aziz, D. C., Z. Hanna, and P. Jolicoeur. 1989. Severe immunodeficiency disease induced by a defective murine leukemia virus. Nature (London) 338:505-508.
38. Huang, M., C. Simard, and P. Jolicoeur. 1989. Immunodeficiency and clonal growth of target cells induced by helper-free defective retrovirus. Science 246:1614-1617.
39. Cheung, S. C., S. K. Chattopadhyay, H. C. Morse III, et al. 1991. Expression of defective virus and cytokine genes in murine AIDS. J. Virol. 65:823-828.
40. Huang, M., C. Simard, D. G. Kay, et al. 1991. The majority of cells infected with the defective murine AIDS virus belong to the B-cell lineage. J. Virol. 65:6562-6571.
41. Heise, M., K. Chow, and O. Kanagawa. 1993. Interaction between T cells and murine acquired immunodeficiency virus superantigen: effect of second signal on T cell reactivity to the MAIDS virus superantigen. Int. Immunol. 5:583-590.
42. Aldrovandi, G., and J. Zack. 1996. Replication and pathogenicity of human immunodeficiency virus type 1 accessory gene mutants in SCID-hu mice. J. Virol. 70:1505-1511.
43. Klinken, S, P., T. N. Fredrickson, J. W. Hartley, et al. 1988. Evolution of B cell lineage lymphomas in mice with retrovirus-induced immunodeficiency syndrome. MAIDS. J. Immunol. 140:1123-1131.
44. Tang, Y., S. K. Chattopadhyay, J. W. Hartley, et al. 1994. Clonal outgrowths of T and B cells in SCID mice reconstituted with cells from mice with MAIDS. In Vivo 8:953-959.
45. Tyor, W. R., C. Power, H. E. Gendelman, et al. 1993. A model of human immunodeficiency virus encephalitis in scid mice. Proc. Natl. Acad. Sci. USA 90:8658-8662.
46. Haas, M., and A. Meshorer. 1979. Reticulum cell neoplasms induced in C57BL/6 mice by cultured virus grown in stromal hematopoietic cell lines. J. Natl. Cancer Inst. 63:427-439.
47. Laterjet, R., and J. F. Duplan. 1962. Experiments and discussion on leukemogenesis by cell-free extract of radiation-induced leukemia in mice. Int. J. Radiat. Biol. 5:339.
48. Mosier, D. E., R. A. Yetter, and H. C. Morse III. 1987. Functional T lymphocytes are required for a murine retrovirus-induced immunodeficiency disease (MAIDS). J. Exp. Med. 165:1737-1742.
49. Yetter, R. A., R. M. L. Buller, J. S. Lee, et al. 1988. CD4+ T cells are required for development of a murine retrovirus-induced immunodeficiency syndrome (MAIDS). J. Exp. Med. 168:623-635.
50. Pattengale, P. K., C. R. Taylor, T. Twomey, et al. 1982. Immunopathology of B-cell lymphomas induced in C57BL/6 mice by dualtropic murine leukemia virus (MuLV). Am. J. Pathol. 107:362-377.
51. Cerny, A., A. W. Hugin, R. R. Hardy, et al. 1990. B cells are required for induction of T cell abnormalities in a murine retrovirus-induced immunodeficiency syndrome. J. Exp. Med. 171:315-320.
52. Hiromatsu, K., Y. Aoki, M. Makino, et al. 1994. Increased Fas antigen expression in murine retrovirus-induced immunodeficiency syndrome, MAIDS. Eur. J. Immunol. 24:2446-2451.
53. Kanagawa, O., B. A. Vaupel, S. J. Korsmeyer, et al. 1995. Apoptotic death of lymphocytes in murine acquired immunodeficiency syndrome: involvement of Fas-Fas ligand interaction. Eur. J. Immunol. 25:2421-2427.
54. Holmes, K. L., H. C. Morse III, M. Makino, et al. 1990. A unique subset of normal murine CD4+ T cells lacking Thy-1 is expanded in a murine retrovirus-induced immunodeficiency syndrome. MAIDS. Eur. J. Immunol. 20:2783-2787.
55. de Leval, L., M. Deprez, S. Colombi, et al. 1995. Morphological changes of thymus in retrovirus-induced murine acquired immunodeficiency syndrome (MAIDS). Pathol. Res. Pract. 191:506-512.
56. Colombi, S., M. Deprez, L. de Leval, et al. 1994. Thymus involvement in murine acquired immunodeficiency (MAIDS). Thymus 23:27-37.
57. Koch, S., G. Muralidhar, and S. L. Swain. 1994. Both naive and memory CD4 T cell subsets become anergic during MAIDS and each subset can sustain disease. J. Immunol. 152:5548-5556.
58. Gazzinelli, R. T., M. Makino, S. K. Chattopadhyay, et al. 1991 CD4+ subset regulation in viral infection: preferential activation of Th2 cells during progression of retrovirus-induced immunodeficiency in mice. J. Immunol. 148:182-188.
59. Cheung, S. C., S. K. Chattopadhyay, J. W. Hartley, et al. 1991 Aberrant expression of cytokine genes in peritoneal macrophages from mice infected with LP-BM5 MuLV, a murine model of AIDS. J. Immunol. 146:121-127.
60. Kanagawa, O., B. Vaupel, S. Gayama, et al. 1993. Resistance of mice deficient in IL-4 to retrovirus-induced immunodeficiency syndrome (MAIDS). Science 262:240-242.
61. Gilmore, G., R. Morawetz, T. Doherty, et al. 1994. Resistance to murine acquired immunodeficiency syndrome (technical comment). Science 265:264-267.
62. Hügin, A. W., M. S. Vacchio, and H. C. Morse III. 1991. A virus-encoded superantigen in a retrovirus-induced immunodeficiency syndrome of mice. Science 252:424-427.
63. Gilmore, G., C. Cowing, and D. Mosier. 1993. LP-BM5 murine retrovirus-induced immunodeficiency disease in allogeneic SCID chimeric mice. J. Immunol. 150:185-189.
64. Doyon, L., C. Simard, R-F. Sékaly, et al. 1996. Evidence that the murine AIDS defective virus does not encode a superantigen. J. Virol. 70:1-9.
65. Makino, M., S. Chattopadhyay, J. Hartley, et al. 1992. Analysis of role of CD8+ T cells in resistance of murine AIDS in A/J mice. J. Immunol. 149:1702-1706.
66. Makino, M., W. Davidson, T. Frederickson, et al. 1991. Effects of non-MHC loci on resistance to retrovirus-induced immunodeficiency in mice. Immunogenetics 33:345-351.
67. Hartley, J. W., T. N. Fredrickson, R. A. Yetter, et al. 1989. Retrovirus-induced murine acquired immunodeficiency syndrome: natural history of infection and differing susceptibility of inbred mouse strains. J. Virol. 63:1223-1231.
68. Kim, W., Y. Tang, J. Kenny, et al. 1994. In murine AIDS, B cells are early targets of defective virus and are required for efficient infection and expression of defective virus in T cells and macrophages. J. Virol. 68:6767-6769.
69. Jolicoeur, P., Z. Hanna, D. Aziz, et al. 1991. The murine acquired immunodeficiency syndrome (MAIDS J induced by the Duplan strain retrovirus. In H. Fan, I. Chen. N. Rosenberg, et al. (ed.), Viruses that affect the immune system. American Society for Microbiology, Washington, D.C
70. Lusso, P., F. D-M. Veronese, B. Ensoli, et al. 1990. Expanded HIV-1 cellular tropism by phenotypic mixing with murine endogenous retroviruses Science 247:848-851.
71. McCune, J. M., R. Namikawa, C-C. Shih, et al. 1989. The SCID-hu mouse: a small animal model for HIV infection and antiviral testing, p. 1046-1049 In F Melchers (ed.), Progress in immunology, vol. 7. Springer-Verlag, Berlin.
72. McCune, J., H. Kaneshima, J. Krowka, et al. 1991. The SCID-hu mouse: a small animal model for HIV infection and pathogenesis. Ann. Rev. Immunol. 9:399-429.
73. McCune, J. M. 1992. The SCID-hu mouse: a small animal model for the analysis of human hematolymphoid differentiation and function. Bone Marrow Transplant 9(Suppl. 1):74-76.
74. Chen, I. S., and J. A. Zack. 1994. Modeling human retroviral pathogenesis and antiretroviral gene therapy in the SCID mouse. Res Immunol. 145:385-392.
75. Lane, H. C., H. Mazur, L. C. Edgar, et al. 1983. Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N. Engl. J. Med. 309:453-458.
76. Herndier, B. G., B. T. Shiramizu, and M. S. McGrath. 1992. AIDS associated non-Hodgkin's lymphomas represent a broad spectrum of monoclonal and polyclonal lymphoproliferative processes. Curr Topics Microbiol. Immunol. 182:385-394.
77. Picchio, G. R., R. Kobayashi, M. Kirven, et al. 1992. Heterogeneity among Epstein-Barr virus-seropositive donors in the generation of immunoblastic B-cell lymphomas in SCID mice receiving human peripheral blood leukocyte grafts. Cancer Res. 52:2468-2477.
78. Mosier, D. E., G. R. Picchio, S. M. Baird, et al. 1992. Epstein-Barr virus-induced human B-cell lymphomas in SCID mice reconstituted with human peripheral blood leukocytes. Cancer Res. 52:5552s-5553s.
79. Rowe, M., L. S. Young, H. Crocker, et al. 1991. Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: implications for the pathogenesis of EBV-positive lymphomas in man. J. Exp. Med. 173:147-158.
80. Wain-Hobson, S. 1989. HIV genome variability in vivo. AIDS 3(Suppl. 1):S13-S18.
81. Boyle, M. J., M. Connors, M. E. Flanigan, et al. 1995. The human HIV/peripheral blood lymphocyte (PBL)-SCID mouse: a modified human PBL-SCID model for the study of HIV pathogenesis and therapy. J. Immunol. 154:6612-6623.
82. Pang, S., Y. Shlesinger, E. S. Daar, et al. 1992. Rapid generation of sequence variation during primary HIV-1 infection. AIDS 6:453-460. (Erratum in AIDS 6:606.)
83. Jamieson, B., G. Aldrovandi, V. Planelles, et al. 1994. Requirement of human immunodeficiency virus type 1 nef for in vivo replication and pathogenicity. J. Virol. 68:3478-3485.
84. Kestler, H., D. Ringler, K. Mori, et al. 1991. Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65:651-662.
85. Mosier, D., R. Gulizia, P. MacIsaac, et al. 1993. Resistance to human immunodeficiency virus-1 infection of SCID mice reconstituted with peripheral blood leukocytes for donors vaccinated with vaccinia gp160 and recombinant gp160. Proc. Natl. Acad. Sci. USA 90:2443-2447.
86. Westby, M., F. Manca, and A. Dalgleish. 1996 The role of host immune responses in determining the outcome of HIV infection. Immunol. Today 17:120-126.
87. Mosier, D., and H. Sieburg. 1994. Macrophage-tropic HIV: critical for AIDS pathogenesis? Immunol. Today 15:332-339.
88. Michael, N., G. Chang, L. D'Arcy, et al. 1995. Defective accessory genes in a human immunodeficiency virus type 1-infected long-term survivor lacking recoverable virus. J. Virol. 69:4228-4236.
89. Maldarelli, F., H. Sato, E. Berthold, et al. 1995. Rapid induction of apoptosis by cell-to-cell transmission of human immunodeficiency virus type 1. J Virol 69:6457-6465.
90. Nardelli, B., C. Gonzalez, M. Schecter, et al. 1995. CD4+ blood lymphocytes are rapidly killed in vitro by contact with autologous human immunodeficiency virus-infected cells. Proc. Natl Acad. Sci. USA 92:7312-7316.
91. Finkel, T., G. Tudor-Williams, N. Banda, et al. 1995. Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes. Nature Med. 1:129-134.
92. Hu, S-L., S. G. Kosowshi, and J. M. Dalrymple. 1986. Expression of AIDS virus envelope gene in recombinant vaccinia viruses. Nature 320:537-540.
93. Redfield, R. R., D. L. Birx, N. Ketter, et al. 1991. A phase-I evaluation of the safety and immunogenicity of vaccination with recombinant gp160 in patients with early human immunodeficiency virus infection. N. Engl. J. Med. 324:1677-1684.
94. Koenig, S., A. Conley, Y. Brewah, et al. 1995. Transfer of HIV-1-specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression. Nature Med. 1:330-336.
95. van Kuyk, R., B. E. Torbett, R. J. Gulizia, et al. 1994. Cloned human CD8+ cytotoxic T lymphocytes protect human peripheral blood leukocyte-severe combined immunodeficient mice from HIV-1 infection bv an HLA-unrestricted mechanism. J. Immunol. 153:4826-4833.
96. Burton, D. R., J. Pyati, R. Koduri, et al. 1994. Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody. Science 266:1024-1027.
97. Parren, P., H. Ditzel, R. Gulizia, et al. 1995. Protection against HIV-1 infection in hu-PBL-SCID mice by passive immunization with a neutralizing human monoclonal antibody against the gp120 CD4-binding site, AIDS 9:1-6.
98. Walker, C. M., D. J. Moody, D. P. Stites, et al. 1989. CD8 T lymphocyte control of HIV replication in cultured CD4 cells varies among infected individuals. Cell Immunol. 119:470-475.
99. Milman, G., and P. D'Souza. 1990. HIV infections in SCID mice: safety considerations. ASM News 56:639-643.
100. Roths, J. B., J. D. Marshall, R. D. Allen, et al. 1990. Spontaneous Pneumocystis carinii pneumonia in immunodeficient mutant scid mice: natural history and pathobiology. Am. J. Pathol. 136:1173-1186.
101. Ho, D., A. Neumann, A. Perelson, et al. 1995. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373:123-126.
102. Wei, X., S. Ghosh, M. Taylor, et al. 1995. Viral dynamics in human immunodeficiency virus type-I infection. Nature 373:117-122.
103. Coffin, J. 1995. HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science 267:483-489.
104. Greiner, D. L., L. D. Shultz, J. Yates, et al. 1995. Improved engraftment of human spleen cells in NOD/LtSz-scid/scid mice as compared with C.B-17-scid/scid mice. Am. J. Pathol. 146:888-902.
105. Kamel-Reid, S., and J. E. Dick. 1988. Engraftment of immune-deficient mice with human hematopoietic stem cells. Science 242:1706-1709.
106. Lapidot, T., F. Pflumio, M. Doedens, et al. 1992. Cytokine stimulation of multilineage hematopoiesis from immature human cells engrafted in SCID mice. Science 255:1137-1141.